The Evolving World of Social & Digital Media Intelligence


It is no secret that social media is an essential channel for expressing opinions and sharing facts. Depicted through visual representations and the written word, the world works fundamentally through online channels, without which we would be thrown back into a rudimentary and non-progressive lifestyle.  

Social media has given the world a glimpse of the amazing accomplishments the healthcare industry has achieved, as well as what we can bring about in the future.  From various research on the selection of molecular candidates and all phases of clinical trials, to drug launches and promotional campaigns, the healthcare sector now heavily relies on insights from social media platforms. 

Information-sharing and peer support social media platforms have both directly and indirectly enabled the healthcare industry to improve the quality of medication and care, while aiding online communities and individuals dealing with various ailments.  PulseTraQ, a unique digital and social media intelligence, has been created to further advance the way pharmaceutical companies gather data and enhance efficiency. 

Through PulseTraQ we create topline social intelligence reports for our clients…

Here is an example of an intelligence report focused on Rheumatoid Arthritis.  Through the intelligence of PulseTraQ, our social media analysis revealed that within the last 5 years the treatment space for rheumatoid arthritis has evolved and seen improvements in terms of efficancy and reduced disease progression.  Additionally, we can conclude that although certain prescribed medications were observed in conjunction with rheumatoid arthritis, they also cater to other diseases such as Psoriatic Arthritis, Ankylosing Spondylitis, Crohn’s disease, Ulcerative Colitis, various forms of cancer, as well as other common and rare indications.

The range of benefits PulseTraQ offers continues to expand as the need for more specific social and digital intelligence analyses grows.  Through PulseTraQ, we can look at search trends for different brands, share of voice for brands and biosimilars, monthly brand mentions, and top keywords.  The rich, unprompted sentiments expressed by the patient and medical community through social media platforms acts as an invaluable source of input, to better the healthcare field. 

PulseTraQ is an indispensable tool for pharmaceutical and healthcare companies that we are excited to offer throughout the industry. A full social intelligence report includes everything from brand mentions, SERP analysis, and geographic splits, to historical analysis, top reporters’ data, and so much more.

To see a full social intelligence report and how PulseTraQ can help your strategic initiatives, download the full report below!


Similar posts:

By Volker Schuster on February 29, 2024

What rare disease day means for our work at SAI Every leap year, on the 29th of February, the world pauses to acknowledge Rare Disease Day—a beacon of solidarity for the millions navigating the labyrinth of rare and often isolating medical conditions. It’s a day that transcends boundaries, echoing the voices of patients, caregivers, and […]

By Maren Nordhoy on July 14, 2023

In the dynamic world of pharmaceutical services, strategic investments play a vital role in shaping the future of organizations. We are happy to announce that we have recently made headlines with our strategic acquisitions of Fulcrum Research Group (FRG) and Pharmaforce International (PFI). To shed light on the motivations behind these investments and the vision driving SAI MedPartners forward, we had the privilege of sitting down with the company’s CEO, Erik Nordhoy.

By Helena Mello, PhD on September 19, 2022

There are over 7,000 rare diseases described, affecting about 20-30 million people in the U.S. alone, according to the NIH. While each condition has its specificities, there are common challenges in the rare disease space, such as finding patients and leveraging centers of excellence and referral networks. This article discusses such challenges and how partnering with SAI’s subject matter experts can help overcome them.

Connect with us on LinkedIn for up-to-the-minute insights

Scroll to top